Lanxib

Lansoprazole, the active ingredient in Lanxib, is a proton pump inhibitor presented as a tablet for oral use. It reduces gastric acid production and is prescribed for conditions such as gastro‑esophageal reflux disease, peptic ulcer disease, and erosive esophagitis.

GNH USA supplies Lanxib as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU GMP standards and providing reliable logistics for global distribution.

Lanxib (lansoprazole) is used to manage acid‑related gastrointestinal disorders.

- Gastro‑esophageal reflux disease (GERD): alleviates heartburn and reflux symptoms by reducing stomach acid. - Peptic ulcer disease: promotes ulcer healing and prevents recurrence through acid suppression. - Helicobacter pylori eradication regimens: acts as a component of combination therapy to increase antibiotic efficacy. - Erosive esophagitis: facilitates mucosal healing by lowering gastric acidity.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Headache: mild to moderate pain often transient. - Diarrhea: loose stools occurring during treatment. - Nausea: feeling of sickness without vomiting. - Abdominal pain: discomfort or cramping in the stomach area. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile infection: severe diarrhea with abdominal pain. - Low magnesium (hypomagnesemia): muscle cramps, irregular heartbeat. - Elevated liver enzymes: possible hepatitis signs. - Stevens‑Johnson syndrome/toxic epidermal necrolysis: severe skin blistering. - Interstitial nephritis: kidney inflammation presenting with fever and rash.

Before initiating therapy, consider the following safety measures.

- Assess renal function: adjust use in patients with severe impairment. - Monitor magnesium levels: prolonged therapy may cause hypomagnesemia. - Use with caution in hepatic impairment: reduced metabolism may increase exposure. - Avoid in known hypersensitivity: discontinue if allergic signs appear. - Review concomitant medications: potential for clinically relevant interactions. - Store at room temperature: keep in the original pack, protect from moisture.

Lansoprazole can affect the absorption or metabolism of several drugs.

Major Interactions (Avoid): - Clarithromycin: increased risk of cardiac arrhythmias. - Ketoconazole: markedly reduced antifungal absorption. - Atazanavir: decreased antiviral efficacy. - Rilpivirine: diminished HIV‑1 viral suppression. - Voriconazole: altered antifungal plasma levels.

Moderate Interactions (Monitor Closely): - Digoxin: increased serum concentrations. - Methotrexate: reduced clearance, risk of toxicity. - Warfarin: enhanced anticoagulant effect. - Diazepam: elevated plasma levels. - Iron salts: decreased iron absorption.